151 related articles for article (PubMed ID: 21554043)
1. Joint genitourinary cancer symposium between Egyptian and American centers.
Zaghloul MS
Expert Rev Anticancer Ther; 2011 May; 11(5):697-9. PubMed ID: 21554043
[TBL] [Abstract][Full Text] [Related]
2. Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: part 2 - prostate and bladder cancer.
Buti S; Ciccarese C; Iacovelli R; Bersanelli M; Scarpelli M; Lopez-Beltran A; Cheng L; Montironi R; Tortora G; Massari F
Future Oncol; 2016 Sep; 12(17):1971-4. PubMed ID: 27312584
[TBL] [Abstract][Full Text] [Related]
3. Organ and functional preservation in the management of genitourinary cancer: bladder, prostate, and penis.
Kuten A; Liu L; Glicksman AS
Cancer Invest; 1995; 13(1):108-24. PubMed ID: 7834465
[No Abstract] [Full Text] [Related]
4. Double primary cancers of the prostate and bladder: a literature review.
Kinoshita Y; Singh A; Rovito PM; Wang CY; Haas GP
Clin Prostate Cancer; 2004 Sep; 3(2):83-6. PubMed ID: 15479490
[TBL] [Abstract][Full Text] [Related]
5. [Management of bladder cancer associated with prostate cancer].
Bonnal JL; Irani J; Maidenberg M; Théodore C; Mauroy B
Prog Urol; 2003 Dec; 13(6):1286-9. PubMed ID: 15000300
[TBL] [Abstract][Full Text] [Related]
6. Small cell carcinoma of the bladder and prostate.
Abbas F; Civantos F; Benedetto P; Soloway MS
Urology; 1995 Nov; 46(5):617-30. PubMed ID: 7495110
[No Abstract] [Full Text] [Related]
7. Impact of previous radiotherapy for prostate cancer on clinical outcomes of patients with bladder cancer.
Yee DS; Shariat SF; Lowrance WT; Sterbis JR; Vora KC; Bochner BH; Donat SM; Herr HW; Dalbagni G; Sandhu JS
J Urol; 2010 May; 183(5):1751-6. PubMed ID: 20299035
[TBL] [Abstract][Full Text] [Related]
8. Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: part 1 - kidney cancer.
Buti S; Ciccarese C; Iacovelli R; Bersanelli M; Scarpelli M; Lopez-Beltran A; Cheng L; Montironi R; Tortora G; Massari F
Future Oncol; 2016 Sep; 12(17):1967-70. PubMed ID: 27312426
[TBL] [Abstract][Full Text] [Related]
9. Examining the co-occurrence of bladder and prostate cancer: a worthwhile investigation?
Kellen E; Zeegers MP; Joniau S; Buntinx F
Future Oncol; 2007 Oct; 3(5):515-9. PubMed ID: 17927517
[TBL] [Abstract][Full Text] [Related]
10. Current standards of care in bladder and prostate rhabdomyosarcoma.
Kieran K; Shnorhavorian M
Urol Oncol; 2016 Feb; 34(2):93-102. PubMed ID: 26776454
[TBL] [Abstract][Full Text] [Related]
11. [Congress of the American Society of Urology (ASU), San Antonio (Texas), May 15-20, 1993].
Boiteux JP
Bull Cancer; 1994 Jan; 81(1):70-3. PubMed ID: 7524820
[No Abstract] [Full Text] [Related]
12. Maximizing outcomes in genitourinary cancers across the treatment continuum.
Fitzpatrick JM; Bellmunt J; Dreicer R; Fleshner NE; Logothetis CJ; Moul JW; Tombal B; Zlotta A
BJU Int; 2011 Apr; 107 Suppl 2():1-12. PubMed ID: 21382149
[TBL] [Abstract][Full Text] [Related]
13. [New therapies for urologic cancer diseases. The Danish Society of Urology].
Lund L; Borre M; Hermann GG; Svolgaard N;
Ugeskr Laeger; 2008 Mar; 170(12):1057. PubMed ID: 18397675
[No Abstract] [Full Text] [Related]
14. Management of advanced cancer of prostate and bladder. Proceedings of a symposium on the tenth anniversary of EORTC, Leeds, England, October 3rd, 1986 and the Fifth Course in Urological Oncology, Erice, Sicily, November 28-December 4th, 1986.
Prog Clin Biol Res; 1988; 260():1-658. PubMed ID: 3362877
[No Abstract] [Full Text] [Related]
15. Occurrence of both bladder and prostate cancer in five cancer registries in Belgium, The Netherlands and the United Kingdom.
Kellen E; Zeegers MP; Dirx M; Houterman S; Droste J; Lawrence G; Truyers C; Bruckers L; Molenberghs G; Joniau S; Buntinx F
Eur J Cancer; 2007 Jul; 43(11):1694-700. PubMed ID: 17531466
[TBL] [Abstract][Full Text] [Related]
16. Improvements in the Treatment of Patients Suffering from Bladder-Prostate Rhabdomyosarcoma: A Report from the CWS-2002P Trial.
Seitz G; Fuchs J; Sparber-Sauer M; Leuschner I; Godzinski J; Klingebiel T; Schuck A; Martus P; Dantonello TM; Koscielniak E
Ann Surg Oncol; 2016 Nov; 23(12):4067-4072. PubMed ID: 27387676
[TBL] [Abstract][Full Text] [Related]
17. How could imaging reduce therapy-associated morbidity in rhabdomyosarcoma of the bladder or prostate?
Kuru TH; Roethke M; Fenchel M; Hadaschik BA
Future Oncol; 2013 Dec; 9(12):1797-800. PubMed ID: 24143879
[No Abstract] [Full Text] [Related]
18. Genitourinary cancers in older adults.
Morganstern D; Garnick MB
Clin Geriatr Med; 1998 May; 14(2):333-65. PubMed ID: 9536109
[TBL] [Abstract][Full Text] [Related]
19. [When should the primary tumor of metastatic bladder or prostate cancer be treated using a nonsurgical regimen?].
Bottke D; Bolenz C; Ott S; Cebulla A; Wiegel T
Urologe A; 2017 May; 56(5):579-584. PubMed ID: 28349190
[TBL] [Abstract][Full Text] [Related]
20. Morphology and therapeutic strategies for neuroendocrine tumors of the genitourinary tract.
Helpap B
Cancer; 2002 Oct; 95(7):1415-20. PubMed ID: 12237909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
